A Crossover Study to Evaluate the Efficacy of Simvastatin in Elevating HDL-C Levels in Patients With Type 2 Diabetes (0733-216)(COMPLETED)

A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Balanced, Three-Way Crossover Study to Evaluate the Efficacy of Simvastatin Therapy in Elevating HDL-C Levels in Patients With Type 2 Diabetic Dyslipidemia and Low HDL-C

The purpose of this study is to see how well simvastatin raises HDL levels in patients with Type 2 Diabetes.

Inclusion Criteria:

• Patient has stable Type 2 diabetes mellitus at Visit 1.
• Patient meets screening criteria based on Visit 1 lab tests

Exclusion Criteria:

• Patient is pregnant, breastfeeding, or at risk of becoming pregnant
• Patient has heart disease, uncontrolled high blood pressure, or other significant disease
• Patient is taking prohibited medication(s) and is unable to stop taking them for the duration of the study